Article Information
History
- May 29, 2020.
Article Versions
- Version 1 (May 25, 2020 - 03:39).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alina S. Shomuradova1,
- Murad S. Vagida1,
- Savely A. Sheetikov1,
- Ksenia V. Zornikova1,
- Dmitry Kiryukhin1,
- Aleksei Titov1,
- Iuliia O. Peshkova1,
- Alexandra Khmelevskaya1,
- Dmitry V. Dianov1,
- Maria Malasheva1,
- Anton Shmelev1,
- Yana Serdyuk1,
- Dmitry V. Bagaev2,
- Anastasia Pivnyuk3,
- Dmitrii S. Shcherbinin4,5,
- Alexandra V. Maleeva1,
- Naina T. Shakirova1,
- Artem Pilunov1,
- Dmitry B. Malko1,
- Ekaterina G. Khamaganova1,
- Bella Biderman1,
- Alexander Ivanov6,
- Mikhail Shugay3,4,5,* and
- Grigory A. Efimov1,**
- 1National Research Center for Hematology, Moscow, Russia
- 2Eindhoven University of Technology, Eindhoven, Netherlands
- 3Center of Life Sciences, Skolkovo Institute of Science and Technology
- 4Pirogov Russian Medical State University, Moscow, Russia
- 5Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
- 6Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia
- ↵* Correspondence: mikhail.shugay{at}gmail.com
↵** Lead Contact: efimov.g{at}blood.ru
Posted May 29, 2020.
SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T-cell receptors
